Microbix Biosystems (TSE:MBX) Share Price Crosses Below 50 Day Moving Average – Should You Sell?

Microbix Biosystems Inc. (TSE:MBX) shares passed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of C$0.30 and traded as low as C$0.28. Microbix Biosystems shares last traded at C$0.28, with a volume of 70,061 shares.

Microbix Biosystems Stock Performance

The company has a debt-to-equity ratio of 27.69, a current ratio of 6.89 and a quick ratio of 5.57. The company’s fifty day moving average price is C$0.30 and its 200 day moving average price is C$0.27. The company has a market cap of C$38.35 million, a PE ratio of -7.78 and a beta of 0.76.

Microbix Biosystems (TSE:MBX) last issued its quarterly earnings data on Thursday, August 13th. The company reported C($0.01) earnings per share (EPS) for the quarter. The firm had revenue of C$4.06 million during the quarter. Microbix Biosystems had a negative return on equity of 18.83% and a negative net margin of 31.72%. On average, equities research analysts predict that Microbix Biosystems Inc. will post 0.02 earnings per share for the current year.

Microbix Biosystems Company Profile

Microbix Biosystems Inc creates proprietary biological products for human health, with over 120 skilled employees and revenues of C$ 18.6 million in its last reported fiscal year (2025). It enables the worldwide commercialization of diagnostic assays by making a wide range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs ¿ ) and reference materials (QUANTDx ¿ ) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows.